Simple Summary Magnetic hyperthermia therapy is an alternative treatment for cancer that complements traditional therapies and that has shown great promise in recent years. In this …
A Alhadhrami, M Zeshan, HMT Farid - Journal of Taibah University …, 2023 - Taylor & Francis
Lanthanum substitution on spinel Nano particles has a significant repercussion on the several features of materials. Sol–gel (auto-ignition) allowed for the substitution of the rare …
S Carregal‐Romero, AB Miguel‐Coello… - Small, 2022 - Wiley Online Library
Manganese ferrite nanoparticles display interesting features in bioimaging and catalytic therapies. They have been recently used in theranostics as contrast agents in magnetic …
I Castellanos-Rubio, O Arriortua, L Marcano… - Chemistry of …, 2021 - ACS Publications
The currently existing magnetic hyperthermia treatments usually need to employ very large doses of magnetic nanoparticles (MNPs) and/or excessively high excitation conditions (H× …
J Massoudi, M Smari, K Khirouni, E Dhahri… - Journal of Magnetism …, 2021 - Elsevier
This report, investigates the influence of particle size on the structure, vibration, and magnetic properties of superparamagnetic LiFe 5 O 8 nanoparticles, which is annealed at …
Mn x Fe 3-x O 4 (x= 0, 0.1, 0.3 and 0.5) nanoparticles were synthesized using the co- precipitation method and its structural and magnetic properties were correlated to the …
The study was based on understanding the relationship between titanium (Ti) doping amount and magnetic heating performance of magnetite (Fe3O4). Superparamagnetic …
SS Phalake, MS Lad, KV Kadam, SAM Tofail… - ACS …, 2022 - ACS Publications
Optimization of manganese-substituted iron oxide nanoferrites having the composition Mn x Fe1–x Fe2O4 (x= 0–1) has been achieved by the chemical co-precipitation method. The …
JA Peters - Progress in Nuclear Magnetic Resonance …, 2020 - Elsevier
Manganese ferrite nanoparticles are superparamagnetic and have very high saturation magnetization, which makes them candidates for application as MRI contrast agents …